Home/Filings/4/0001209191-21-037641
4//SEC Filing

DRISCOLL FREDERICK W 4

Accession 0001209191-21-037641

CIK 0001419600other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:20 PM ET

Size

7.2 KB

Accession

0001209191-21-037641

Insider Transaction Report

Form 4
Period: 2021-06-01
DRISCOLL FREDERICK W
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-06-01+168,000168,000 total
    Exercise: $8.35Exp: 2031-05-31Common Stock (168,000 underlying)
  • Award

    Common Stock

    2021-06-01+28,00030,680 total
Footnotes (2)
  • [F1]Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
  • [F2]25% of the shares subject to the option shall vest on the one-year anniversary of May 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1
  • filerCIK 0001129890

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:20 PM ET
Size
7.2 KB